Advertisement

Topics

GIZA VENTURE CAPITAL Company Profile

14:25 EST 20th November 2017 | BioPortfolio

GIZA VENTURE CAPITAL established in 1992, is a pioneer investor in seed and early-stage technology companies. Giza currently manages four funds totaling about $500 million.Giza has investment professionals with a wealth of expertise and experience in Communications, Semiconductors, Information Technology, Enterprise Software and Life Sciences.
Giza has invested in 82 companies in the sectors of Communications, Information Technology, Enterprise Software and Life Sciences, with 29 exits. Giza's vision in recognizing future technology leaders led to the following winning investments; Olplus (acquired by Intel, Cyota (acquired by RSA), X Technologies (acquired by Guidant), Precise (NASDAQ:PRSE, acquired by Veritas), Oridion (SWX:ORIDN), Zoran (NASDAQ:ZRAN), M-Systems (NASDAQ:FLSH), DSPG (NASDAQ:DSPG), Butterfly (acquired by TI), DSPC (acquired by Intel), Libit

Location

Ramat Aviv Tower 40 Einstein St. , 12 th floor
Tel Aviv
61172
Israel

Contact

Phone: 972 3 640 2318
Fax: 972 3 640 2319
Email: submitplan@gizavc.com


News Articles [1079 Associated News Articles listed on BioPortfolio]

Scientists Just Found a Hidden Chamber in the Great Pyramid of Giza

Scientists have found a hidden chamber in Egypt’s Great Pyramid of Giza, the first such discovery in the structure since the 19th century and one likely to spark a new surge of interest in the phara...

2016 US Venture Capital Investment into Life Sciences Companies: An Analysis by Evolution Global

In order to elucidate the focus of Venture Capital funding in the Biotechnology sector this year, Evolution Analysts have assessed the deals carried out by the Top 25 US Venture

M&As this week: Woden Venture Capital, Evotec

Woden Venture Capital (Woden) plans to acquire biotechnology company ACCUM Therapeutics for C$4.5m ($3.6m).

Atlas Venture Unveils New $350M Fund for Seed Biotech Investments

Life sciences venture capital firm Atlas Venture now has $350 million in fresh capital to invest in the early stage biotech companies in the U.S. and around the world. The new fund is Cambridge, MA-ba...

Start-ups profit from being in close contact with the venture capital scene

High-Tech Gründerfonds, Bayer Pharma AG, Merck KGaA and the Innovation and Startup Center for Biotechnology (IZB) hosted the 3rd Munich Life Science Pitch Day at the IZB. Eight start-up teams had the...

Ankon raises $100mm

Ankon Technologies Co. Ltd. (devices for gastric diagnosis) raised a $100mm in an undisclosed financing round from Softbank China Venture Capital, Dazhong Investment, Youshi Capital, and Tongsheng Cap...

Women entrepreneurs still lag behind men in accessing new business funding

(Taylor & Francis Group) Women entrepreneurs are finding it increasingly difficult to access venture capital funding for start-up businesses and remain much less likely to attract funding than male en...

Archaeology: The wonder of the pyramids

Andrew Robinson enjoys a volume rounding up research on the complex at Giza, Egypt.

PubMed Articles [126 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

The effect of migration on social capital and depression among older adults in China.

An estimated 9 million elderly people accompanied their adult children to urban areas in China, raising concerns about their social capital and mental health following re-location. The aim of this stu...

Clinical Trials [41 Associated Clinical Trials listed on BioPortfolio]

Prevalence of NNSH in a Group of Egyptian Children Aged 3-8 Years Old in Giza Governorate: A Cross Sectional Study.

1. Prevalence of non-nutritive sucking habits (NNSH) in a group of Egyptian children aged 3-8 years old in Giza Governorate. 2. Assessment of factors associated with NNSH.

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Prevalence of Molar Incisor Hypomineralization Among a Group of Egyptian Children in Giza Governorate

- One single operator will assess the prevalence of molar incisor hypomineralization and its Severity among a group of Egyptian children in Giza Governorate .

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Quest Sound Recover (SR2) vs. Venture SR2

Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform. To investigate the improvements of this feature is compared on a new and older hearing...

Companies [1540 Associated Companies listed on BioPortfolio]

GIZA VENTURE CAPITAL

GIZA VENTURE CAPITAL established in 1992, is a pioneer investor in seed and early-stage technology companies. Giza currently manages four funds totaling about $500 million.Giza has investment professi...

BVK Bundesverband Deutscher Kapitalbeteiligungsgesellschaften German Private Equity and Venture Capital Association e.V.

Bundesverband Deutscher Kapitalbeteiligungsgesellschaften – German Private Equity and Venture Capital Association e.V. (BVK) is the organisation of German venture capital and private equity companie...

Russian Venture Capital Association

The idea to create Russian Venture Capital Association had been expressed at the December 1996 seminar for EBRD regional venture capital fund managers in St.-Petersburg. The RVCA founding meeting was ...

EUROPEAN INVESTMENT FUND

The EIF's activity is centred upon two areas, venture capital and guarantees: EIF's venture capital instruments consist of equity investments in venture capital funds and business incubators that supp...

Morgenthaler

David Morgenthaler founded the firm in 1968 after a successful career as an operating executive. After his venture-backed business was sold to an international company, Dave decided that there was a t...

More Information about "GIZA VENTURE CAPITAL" on BioPortfolio

We have published hundreds of GIZA VENTURE CAPITAL news stories on BioPortfolio along with dozens of GIZA VENTURE CAPITAL Clinical Trials and PubMed Articles about GIZA VENTURE CAPITAL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GIZA VENTURE CAPITAL Companies in our database. You can also find out about relevant GIZA VENTURE CAPITAL Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record